Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Second Quarter Results

                          Wednesday, August 8, 2007
                                4:30 p.m. EDT

    WAKEFIELD, MA, Aug. 1 /CNW/ - NUCRYST Pharmaceuticals Corp. will hold a
webcast at 4:30 p.m. EDT on Wednesday, August 8, 2007 regarding the company's
2007 second quarter results.
    In addition to standard disclosure over wire services, a news release and
financial statements will be posted on the NUCRYST web site. To listen to the
call live on the Internet, please go to www.nucryst.com.
    Scott H. Gillis, President & CEO and Eliot M. Lurier, Vice President,
Finance & Administration and Chief Financial Officer will participate on the
    An audio file of the call will be archived and posted on the NUCRYST web

    NUCRYST Pharmaceuticals (NASDAQ:   NCST; TSX: NCS) develops, manufactures
and commercializes medical products that fight infection and inflammation
using its patented atomically disordered nanocrystalline silver technology.
Smith & Nephew plc sell a range of advanced wound care products under their
Acticoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST's
SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also
developing pharmaceutical products to address medical conditions that are
characterized by both infection and inflammation. The Company has developed
its proprietary nanocrystalline silver in a powder form for use as an active
pharmaceutical ingredient, referred to as NPI 32101.

    %SEDAR: 00023031E

For further information:

For further information: Gillian McArdle, (416) 504-8464,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890